Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
Resource Type
Article
Authors
Lu, Shun ; Zhou, Jianying ; Jian, Hong ; Wu, Lin ; Cheng, Ying ; Fan, Yun ; Fang, Jian ; Chen, Gongyan ; Zhang, Zhihong ; Lv, Dongqing ; Jiang, Liyan ; Wu, Rong ; Jin, Xiangming ; Zhang, Xiaodong ; Zhang, Junhong ; Xie, Conghua ; Sun, Gengyun ; Huang, Dongning ; Cui, Jiuwei ; Guo, Renhua ; Han, Zhigang ; Chen, Zhendong ; Liang, Jin ; Zhuang, Wu ; Hu, Xingsheng ; Zang, Aimin ; Zhang, Yi ; Cang, Shundong ; Lan, Yuanbo ; Chen, Xi ; Liu, Laiyu ; Li, Xingya ; Chen, Jun ; Ma, Rui ; Guo, Yanzhen ; Sun, Ping ; Tian, Panwen ; Pan, Yueyin ; Liu, Zhe ; Cao, Peiguo ; Ding, Lieming ; Wang, Yang ; Yuan, Xiaobin ; Wu, Pengxiang
Source
In The Lancet Respiratory Medicine October 2023 11(10):905-915
Subject
Primary Research Articles
Language
ISSN
2213-2600